NCT05972889已完成不适用
Randomized Blinded Evaluation of the Effects of Transcutaneous Electrical Nerve Stimulation and Interferential Current Compared to a Sham Device and Standard of Care in Patients With Non-Specific Chronic Lower Back Pain
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 334
- 试验地点
- 16
- 主要终点
- Visual Analogue Scale Pain Rating - NexWave vs. Sham
研究概览
简要总结
This is a prospective, sham-controlled, randomized, single-blinded, multi-center study comparing two different modes of the NexWave device, transcutaneous electrical nerve stimulation (TENS) and interferential current (IFC), with an identical non-functioning NexWave sham device or self-defined standard of care for improvement of pain intensity of non-specific CLBP.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- Double (Participant, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Ages 18-70, or older if specified by law
- •Non-specific chronic lower back pain defined as:
- •Having lasted ≥3 months in duration
- •Current Visual Analogue Scale (VAS) pain rating ≥50 out of 100 (or an equivalent of 5 out of 10 on a 10-point scale)
- •No radiating pain below the knee
- •≥75% back or buttock pain rather than lower extremity pain
- •Subjects who are willing and capable of providing informed consent
- •Subjects who are willing and capable of participating in all testing and questionnaire requirements associated with the clinical study
排除标准
- •Any prior home use of the NexWave or any TENS/IFC device
- •Any history of lumbar spine surgery or spinal fractures
- •Subjects with a history of rheumatic disease
- •Subjects with spine disorders, deformities, or severe spinal conditions such as scoliosis and kyphosis, Pott's disease, disc protrusion, or others that can be attributed to specific causes of back pain
- •Subjects currently prescribed and adherent to opioid therapy
- •Current implanted cardiac pacemakers, defibrillators, cardiac pumps, spinal stimulators, or other implanted electronic devices
- •Active psychiatric or uncontrolled mood disorders including subjects on antipsychotic medication, diagnosis of bipolar disorder or schizophrenia, or uncontrolled anxiety or clinical depression
- •Subjects with a known history of allergic reactions to medical adhesives or any condition that could affect placement of the electrodes
- •Women of childbearing potential who are pregnant or who are planning to become pregnant during the anticipated study period
- •Subjects with health conditions that in the Investigator's medical opinion would prevent participation in the study, interfere with assessment or therapy, significantly raise the risk of study participation, or modify outcome data or its interpretation
- •Subjects who are currently enrolled in another investigational study that would directly interfere with the current study
结局指标
主要结局
Visual Analogue Scale Pain Rating - NexWave vs. Sham
时间窗: Four weeks
VAS pain rating between baseline and four weeks for NexWave subjects as compared to sham device subjects.
Visual Analogue Scale Pain Rating - NexWave vs. Control
时间窗: Four weeks
VAS pain rating between baseline and four weeks for NexWave subjects as compared to control or sham device subjects.
次要结局
- Oswestry Disability Index (OD) - NexWave vs. Control(Four weeks)
- Oswestry Disability Index (ODI) - NexWave vs. Sham(Four weeks)
研究者
研究点 (16)
Loading locations...
相似试验
Unknown
不适用
Randomized Trial Comparing Two Sirolimus-Eluting Stents in Diabetes MellitusDiabetes MellitusAcute Coronary SyndromeCoronary Artery DiseaseNCT04660240Instituto Nacional de Cardiologia Ignacio Chavez860
Unknown
4 期
Comparison of Oral Versus Subcutaneous Route of Methotrexate Administration in Moderate to Severe PsoriasisPsoriasis VulgarisNCT03408756Post Graduate Institute of Medical Education and Research, Chandigarh100
已完成
2 期
Aldafermin (NGM282) for Chronic Diarrhea Due to Bile Acid Malabsorption (BAM)Chronic DiarrheaBile Acid MalabsorptionBile Acid DiarrheaBile Acid Malabsorption Syndrome Type IIFunctional DiarrheaIrritable Bowel Syndrome With DiarrheaNCT05130047Michael Camilleri, MD30
尚未招募
不适用
Patient Education in the Clinical Management of PessaryPelvic Organ ProlapseNCT06432218Peking Union Medical College Hospital280
已完成
2 期
Safety and Efficacy of TU-100 as an Adjunct to an Enhanced Recovery After Surgery in Subjects Undergoing Bowel ResectionEnhanced Recovery After SurgeryNCT04742907Tsumura USA402